Benjamin Musher
Distinguished in Cholangiocarcinoma (Bile Duct Cancer)

Dr. Benjamin Musher

Oncology | Gastroenterology
CommonSpirit Health
1919 Old Spanish Trail, 6th Floor, 
Houston, TX 
Accepting New Patients
Offers Telehealth

Distinguished in Cholangiocarcinoma (Bile Duct Cancer)
CommonSpirit Health
1919 Old Spanish Trail, 6th Floor, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Benjamin Musher is a medical oncologist specializing in gastrointestinal cancers. He is the Medical Director of Medical Oncology and Director of the Gastrointestinal Cancer Program at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine (BCM), where he also holds the Barry Smith Endowed Professorship.Dr. Musher received an AB in Social Studies from Harvard University and his MD with Honors from BCM. He completed his residency in internal medicine at the University of Washington’s Department of Medicine, where he was an attending physician. He was later an attending physician and fellow in the Division of Hematology-Oncology at the University of Pennsylvania.Dr. Musher received the Oncology Faculty Educator of the Year for six consecutive years and the Fulbright & Jaworski L.L.P. Faculty Excellence Award, which recognizes BCM faculty for excellence in teaching and evaluation. He has also been recognized with several awards for going above and beyond to deliver exceptional patient experiences; and was named a Top Doctor in 2015 by Houstonia Magazine.Dr. Musher is board-certified in Medical Oncology from the American Board of Internal Medicine and is a member of the American Society of Clinical Oncology.

Dr. Musher is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, and Familial Colorectal Cancer.

His clinical research consists of co-authoring 28 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 1 clinical trial in the study of Cholangiocarcinoma (Bile Duct Cancer).

Graduate Institution
Baylor College Of Medicine - National Student Clearinghouse
Residency
Residency at University of Washington School of Medicine 06/ - Seattle, WA Internal Medicine - 2003
Specialties
Oncology
Gastroenterology
Licenses
Internal Medicine in PA
Fellowships
Fellowship at University of Pennsylvania School of Medicine 06/ - Philadelphia, PA Hematology/Oncology - 2008
Hospital Affiliations
Baylor St. Luke's Medical Center - Houston, TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

1919 Old Spanish Trail, 6th Floor, Houston, TX 77054
Call: 832-957-6500

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug, Radiation, Biological
Study Phase: Phase 2
Exceptional Responders Pilot Study: Molecular Profiling of Tumors From Cancer Patients Who Are Exceptional Responders
Exceptional Responders Pilot Study: Molecular Profiling of Tumors From Cancer Patients Who Are Exceptional Responders
Enrollment Status: Active_not_recruiting
Publish Date: October 20, 2025
Intervention Type: Other
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
Enrollment Status: Completed
Publish Date: June 11, 2025
Intervention Type: Drug
Study Drugs: Cisplatin, Gemcitabine, Nab-Paclitaxel
Study Phase: Phase 3
A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision (PROSPECT)
A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision (PROSPECT)
Enrollment Status: Active_not_recruiting
Publish Date: February 02, 2024
Intervention Type: Procedure, Other, Drug
Study Phase: Phase 2/Phase 3
A Randomized Phase II Study of Perioperative mFOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
A Randomized Phase II Study of Perioperative mFOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 19, 2022
Intervention Type: Drug, Procedure
Study Drugs: Fluorouracil, Gemcitabine hydrochloride, Irinotecan hydrochloride, Oxaliplatin, Paclitaxel albumin-stabilized nanoparticle formulation
Study Phase: Phase 2
Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
Enrollment Status: Terminated
Publish Date: April 12, 2022
A Pilot Study in Gastric Cancer of Assignment to Postoperative Chemoradiation or Chemotherapy Based Upon Surgical Lymph Node Assessment After Preoperative Chemotherapy, With Gene Assay as Correlate of Biologic Response
A Pilot Study in Gastric Cancer of Assignment to Postoperative Chemoradiation or Chemotherapy Based Upon Surgical Lymph Node Assessment After Preoperative Chemotherapy, With Gene Assay as Correlate of Biologic Response
Enrollment Status: Terminated
Publish Date: October 12, 2020
Intervention Type: Radiation, Drug
Study Phase: Early Phase 1
View 6 Less Clinical Trials

28 Total Publications

Unmet supportive care needs in patients with advanced cancer and its impact on distress.
Unmet supportive care needs in patients with advanced cancer and its impact on distress.
Journal: BMC palliative care
Published: January 21, 2025
View All 28 Publications
Similar Doctors
Elite in Cholangiocarcinoma (Bile Duct Cancer)
Dr. Milind M. Javle
Hematology Oncology | Oncology
Elite in Cholangiocarcinoma (Bile Duct Cancer)
Dr. Milind M. Javle
Hematology Oncology | Oncology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
 (0.9 miles away)
713-592-5433
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Milind Javle is a Hematologist Oncology specialist and an Oncologist in Houston, Texas. Dr. Javle is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Pancreatic Cancer, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Elite in Cholangiocarcinoma (Bile Duct Cancer)
Dr. Maen Abdelrahim
Oncology
Elite in Cholangiocarcinoma (Bile Duct Cancer)
Dr. Maen Abdelrahim
Oncology

Tmh Physician Associates PLLC

16605 Southwest Fwy 400 Mob3, Methodist Family Medicine, 
Sugar Land, TX 
 (16.0 miles away)
281-275-0800
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Maen Abdelrahim is an Oncologist in Sugar Land, Texas. Dr. Abdelrahim is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Colorectal Cancer, Hepato-Pancreato-Biliary Surgery, and Tissue Biopsy.

Elite in Cholangiocarcinoma (Bile Duct Cancer)
Dr. Sunyoung S. Lee
Oncology
Elite in Cholangiocarcinoma (Bile Duct Cancer)
Dr. Sunyoung S. Lee
Oncology

MD Anderson

1515 Holcombe Blvd, 
Houston, TX 
 (0.5 miles away)
713-792-2121
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sunyoung Lee is an Oncologist in Houston, Texas. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Fibrolamellar Carcinoma, Gallbladder Cancer, and Hepato-Pancreato-Biliary Surgery.

VIEW MORE CHOLANGIOCARCINOMA (BILE DUCT CANCER) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Musher's expertise for a condition
ConditionClose
    • Distinguished
    • Cholangiocarcinoma (Bile Duct Cancer)
      Dr. Musher is
      Distinguished
      . Learn about Cholangiocarcinoma (Bile Duct Cancer).
      See more Cholangiocarcinoma (Bile Duct Cancer) experts
    • Colorectal Cancer
      Dr. Musher is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Familial Colorectal Cancer
      Dr. Musher is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Familial Pancreatic Cancer
      Dr. Musher is
      Distinguished
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    • Lynch Syndrome
      Dr. Musher is
      Distinguished
      . Learn about Lynch Syndrome.
      See more Lynch Syndrome experts
    • Pancreatic Cancer
      Dr. Musher is
      Distinguished
      . Learn about Pancreatic Cancer.
      See more Pancreatic Cancer experts
    • Advanced
    • Adult Soft Tissue Sarcoma
      Dr. Musher is
      Advanced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Gastroesophageal Junction Cancer
      Dr. Musher is
      Advanced
      . Learn about Gastroesophageal Junction Cancer.
      See more Gastroesophageal Junction Cancer experts
    • Mesenchymoma
      Dr. Musher is
      Advanced
      . Learn about Mesenchymoma.
      See more Mesenchymoma experts
    • Neuroendocrine Tumor
      Dr. Musher is
      Advanced
      . Learn about Neuroendocrine Tumor.
      See more Neuroendocrine Tumor experts
    • Stomach Cancer
      Dr. Musher is
      Advanced
      . Learn about Stomach Cancer.
      See more Stomach Cancer experts
    • Undifferentiated Pleomorphic Sarcoma
      Dr. Musher is
      Advanced
      . Learn about Undifferentiated Pleomorphic Sarcoma.
      See more Undifferentiated Pleomorphic Sarcoma experts
    • Experienced
    • Alveolar Soft Part Sarcoma
      Dr. Musher is
      Experienced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Ampullary Cancer
      Dr. Musher is
      Experienced
      . Learn about Ampullary Cancer.
      See more Ampullary Cancer experts
    • Anal Cancer
      Dr. Musher is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Angiosarcoma
      Dr. Musher is
      Experienced
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    • Appendix Cancer
      Dr. Musher is
      Experienced
      . Learn about Appendix Cancer.
      See more Appendix Cancer experts
    • Astrocytoma
      Dr. Musher is
      Experienced
      . Learn about Astrocytoma.
      See more Astrocytoma experts
    View All 44 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.